DOCSLIB.ORG

Hypersensitivity Response in Rabbits Following Repeated Intradermal Injection of Protein Antigens

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hypersensitivity Response in Rabbits Following Repeated Intradermal Injection of Protein Antigens Timeline • 1903 - Maurice Arthus – Described a stereotypical Hypersensitivity response in rabbits following repeated intradermal injection of protein antigens – The response, characterized by Stephen Canfield, MD PhD local erythema, induration, Assistant Professor hemorrhage and necrosis Division of Pulmonary, Allergy became known as the “Arthus and Critical Care Medicine Reaction” Timeline Timeline • 1893 - Emil von Behring •1906 - Clemens von Pirquet and Bela Schick – Working with diphtheria toxin noted that animals would suffer –Coined the term “serum sickness” to describe strange systemic symptoms enhanced responses and even suffered by some patients weeks death following a second dose after receiving diphtheria or tetanus of toxin too small to injure anti-toxin horse serum normal untreated animals –Postulated for the first time that – Described this phenomenon as these hypersensitivity reactions might “hypersensitivity” be the product of immune response –Named these responses “allergic” from the Greek allos ergos, altered reactivity. All historical photos from Silverstein, AM. 1989. A History of Immunology. Academic Press, San Diego Timeline Definitions •1902 - Charles Richet and Paul Portier •Hypersensitivity: –Set sail on the yacht of the Prince of –Broadest (Abbas) - Disorders caused by immune responses Monacco to study the effects of -Dysregulated response to foreign antigen marine toxins in mammals ‣ ‣-Failure of tolerance to self-antigen –Attempted to protect dogs from the effects of toxins by innoculating them –Practical - Used clinically to refer to aberrant or excessive at low doses immune responses generated against foreign antigens, although the same immune processes apply in many autoimmune disease –Re-exposure to innocuous doses resulted in a rapid shock and •Allergy: suffocation –Symptoms elicited by encounter with foreign antigen in a –Coined the term “ana-phylaxis” to previously sensitized individual emphasize its antithesis to the familiar “prophylaxis” 1 Manifestations of Hypersensitivity Common to All Types •Symptoms frequently are localized to the anatomical site of antigen exposure: • Products of the adaptive immune system Site of Exposure Syndrome Common Allergens Symptoms – Require at least one exposure for sensitization to occur – Nasal Pruritis Sensitization can be long lived in the absence of re- Allergic Rhinitis Rhinorrhea exposure (>10 years) due to immunologic memory Congestion Respiratory Mucosa Bronchospasm Asthma Chronic Airway Inflammation Cramping Vomit/Diarrhea G.I. Mucosa Food Allergy Hives Anaphylaxis Manifestations of Hypersensitivity Type I (Immediate) Hypersensitivity • Antigens: Site of Exposure Syndrome Common Allergens Symptoms – Classically exogenous, as opposed to “self” (autoimmune) – Contact via mucous membranes and at low dose appears Contact Hives Urticaria Pruritis to favor type I sensitization Skin • Reactions: – Occur within seconds-minutes of exposure Contact Rash Dermatitis Pruritis – Severity ranges from irritating to fatal • Immune Effect Hives/Edema Abd. Cramping – Blood Systemic Allergy Initial antigen contact leads to IgE production Bronchospasm Hypotension – On re-exposure, antigen-specific IgE initiates the reaction Hypersensitivity: Gell & Coombs Classification IgE Production •Occurs as part of a secondary immune response (generally multiple or persistent exposures) •Class switch to IgE is directed by IL-4 and IL-13 (Th2 cytokines), and requires T cell help (CD40L) •The propensity to make an IgE response to environmental antigens varies among individuals •“Atopic” individuals are those genetically predisposed to form IgE responses. That is, atopy is heritable Immunobiology (Janeway), 6th Ed. 2 Genetics of Atopy Allergy: Sensitization Phase •Complex, multigenic heritability. Candidate genes: • Serum IgE produced by plasma cells has a short –Chrom. 11q - β-subunit of the high affinity FcεRI Τ1/2 (serum Τ1/2 IgG≈30 days; for IgE≈2 days) –Chrom. 5q - Cytokine cluster: IL-3, IL-4, IL-5, IL-9, IL-13 • Rapidly taken up by FcεRI on tissue mast cells –TIM (T-cell, Ig domain, Mucin domain) - surface and circulating basophils –protein, variation assoc. with IL-4/IL-13 prod. –IL-12 p40 subunit (assoc. with asthma and AD) IgE •Variation in IgE response to specific allergens is associated with MHC II genetics –DRB1*1501 is associated with IgE responses to specific ragweed pollen proteins Allergy Epidemic Allergy: Effector Phase •Type I Hypersensitivity diseases, including asthma and •Early Phase Response: within seconds-minutes allergic rhinitis, have been increasing in prevalence in –IgE crosslinking by antigen ¿ release of preformed mediators the economically “advantaged” parts of the world for 30 years –histamine ¿ smooth muscle constriction, mucous secretion, ↑vascular permeability, ↑GI motility, sens. nerve stimulation –The “hygiene hypothesis” attributes increased allergic disease rates to generally decreasing microbial exposure in early life which would normally provide a Th1-promoting effect Allergen IgE ‣-Neonatal bias: ↓IL-12 (DC) and ↓IFN-γ (T cells) ‣-Birth order: ↓allergy rates among 3rd- and 4th-born children ‣-Protective effect of day care ‣-1990 - East/West Berlin immediately after the wall fell: East had ‣-↓vaccination rates, ↑prev. childhood infection, but ↓’ed asthma ‣-Hx of measles or HAV infection, or +PPD ¿↓allergy rates Allergy Epidemic Allergy: Effector Phase •Weighing against the Hygiene Hypothesis: •Early Phase Response: within seconds-minutes –Despite this epidemiologic data, some evidence is hard to –IgE crosslinking by antigen ¿ release of preformed mediators reconcile –histamine ¿ smooth muscle constriction, mucous secretion, ↑vascular ‣-Previous infection with helminths, which generates a strong Th2 permeability, ↑GI motility, sens. nerve stimulation response, is also associated with protection against allergy ‣-Early life exposure to pathogens is also associated with decreased Allergen risk of autoimmune disease (e.g., type I diabetes), a classic Th1- mediated condition IgE –Revised hygiene hypothesis - early life exposure to microbial pathogens influences the balance of immune responsive vs. immune modulating influences 3 Allergy: Effector Phase FcεRI Signaling •Structure: •Early Phase Response: within seconds-minutes –Alpha, Beta, Gamma-Gamma –IgE crosslinking by antigen ¿ release of preformed mediators •Alpha - binds IgE monomer –histamine ¿ smooth muscle constriction, mucous secretion, ↑vascular •Beta, Gamma - signal permeability, ↑GI motility, sens. nerve stimulation •ITAM’s Allergen –Conserved sequences within the IgE receptor tail containing tyrosines –ITAM Tyr is phosphorylated on ligand binding Immediate –Serve as docking sites for downstream Histamine Proteases Hours activating kinases Heparin Minutes Cytokines: Prostaglandins IL-4, IL-13 Leukotrienes Allergy: Effector Phase Eosinophils • Innate responder cell in Type I hypersensitivity •Late Phase Response: 6-24 hours after exposure – Production in marrow induced by IL-3, IL-5, GM-CSF –Mast cell production of newly synthesized mediators – Chemotax to tissue sites: IL-5, Eotaxin-1, 2, 3 ‣-Leukotrienes ¿ smooth mm. contraction, vasodil., chemotaxis ‣-Cytokines ¿ recruitment of PMN and eosinophils – “Primed” by IL-5, eotaxins, C5a ‣ -↑FcγR and C’ receptor expression ‣ -induce FcεR expression Allergen ‣ -↓threshold for degranulation IgE – On activation, eosinophils secrete ‣ -Toxic proteins- major basic protein, eos. cationic ‣ -protein, eos. derived neurotoxin Immediate Histamine ‣ -IL-3, IL-5, GM-CSF, IL-8 Proteases Hours Heparin Minutes Cytokines: ‣ -LT’s Prostaglandins IL-4, IL-13 Leukotrienes Evolutionary Role of Type I Mast Cell Degranulation Response Pre-exposure to Ag Post-exposure to Ag • Mast cells line all subepithelial mucosa – Rapid recruitment of PMN, eosinophils, monocytes to sites of pathogen entry – ↑Lymph flow from peripheral sites to lymph node – ↑G.I. motility ¿ favors expulsion of G.I. pathogens • Important role in parasite clearance –/– – c-kit mice have no mast cells ¿↑susceptibility to trichinella, strongyloides – Eosinophil depletion (Ab-mediated) ¿↑severity of schistosomal infection 4 Evolutionary Role of Type I Anaphylaxis Response •STAT6: •Response to systemic circulation of allergen –Mediates IL-4/IL-13 signaling –Triggering of mast cells in peri-vascular tissue –Required for IgE class switch –Circulating histamine, PG’s/LT’s ¿ vascular leak, vasodilatation –STAT6–/– mice have no IgE –High-output shock (increased cardiac output, ↓↓BP) •Wild type or STAT6–/– mice –Other symptoms: urticaria, flushing, wheeze, laryngeal edema with were injected with 500 N. airway compromise, G.I. cramping, diarrhea brasiliensis larvae •Rapid progression over seconds-minutes •Treatment - •Worm counts and fecal egg counts were assessed at 13 –early administration epinephrine I.M., followed by antihistamines (H1 and H2 blockade) ¿ treat early phase days –subsequent administration corticosteroids¿prevent late phase Urban, et al. (1998) Immunity. 8:255 Type II Hypersensitivity: Type I Sensitivity in Allergy Antibody (Ab) Mediated • Target-specific IgM and IgG mediate damage •Type I Hypersensitivity mediates: • Targets: – Allergic Rhinitis/conjunctivitis (Hayfever) – Self-molecules altered by foreign antigen ¿ neo-epitope – Asthma ‣ -penicillin conjugates to RBC surface proteins ¿ new – Food/Medication reactions penicilloated-protein serves as a target for IgM/IgG ¿ – Contact urticaria intravascular hemolysis – Some forms of eczema – Self-molecules unaltered = breaking of
Load more

Recommended publications
  • Differentiating Between Anxiety, Syncope & Anaphylaxis
    Differentiating between anxiety, syncope & anaphylaxis Dr. Réka Gustafson Medical Health Officer Vancouver Coastal Health Introduction Anaphylaxis is a rare but much feared side-effect of vaccination. Most vaccine providers will never see a case of true anaphylaxis due to vaccination, but need to be prepared to diagnose and respond to this medical emergency. Since anaphylaxis is so rare, most of us rely on guidelines to assist us in assessment and response. Due to the highly variable presentation, and absence of clinical trials, guidelines are by necessity often vague and very conservative. Guidelines are no substitute for good clinical judgment. Anaphylaxis Guidelines • “Anaphylaxis is a potentially life-threatening IgE mediated allergic reaction” – How many people die or have died from anaphylaxis after immunization? Can we predict who is likely to die from anaphylaxis? • “Anaphylaxis is one of the rarer events reported in the post-marketing surveillance” – How rare? Will I or my colleagues ever see a case? • “Changes develop over several minutes” – What is “several”? 1, 2, 10, 20 minutes? • “Even when there are mild symptoms initially, there is a potential for progression to a severe and even irreversible outcome” – Do I park my clinical judgment at the door? What do I look for in my clinical assessment? • “Fatalities during anaphylaxis usually result from delayed administration of epinephrine and from severe cardiac and respiratory complications. “ – What is delayed? How much time do I have? What is anaphylaxis? •an acute, potentially
    [Show full text]
  • Early-Phase GVHD Gene Expression Profile in Target Versus Non
    Bone Marrow Transplantation (2013) 48, 284–293 & 2013 Macmillan Publishers Limited All rights reserved 0268-3369/13 www.nature.com/bmt ORIGINAL ARTICLE Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target? B Sadeghi1, H Al-Chaqmaqchi1, S Al-Hashmi1, D Brodin2, Z Hassan1,3, M Abedi-Valugerdi4, A Moshfegh5 and M Hassan1,3 GVHD is a major complication after allo-SCT. In GVHD, some tissues like liver, intestine and skin are infiltrated by donor T cells while others like muscle are not. The mechanism underlying targeted tropism of donor T cells is not fully understood. In the present study, we aim to explore differences in gene expression profile among target versus non-target tissues in a mouse model of GVHD based on chemotherapy conditioning. Expression levels of JAK–signal transducers and activators of transcription (STAT), CXCL1, ICAM1 and STAT3 were increased in the liver and remained unchanged (or decreased) in the muscle and kidney after conditioning. At the start of GVHD the expression levels of CXCL9, ITGb2, SAA3, MARCO, TLR and VCAM1 were significantly higher in the liver or kidney compared with the muscle of GVHD animals. Moreover, biological processes of inflammatory reactions, leukocyte migration, response to bacterium and chemotaxis followed the same pattern. Our data show that both chemotherapy and allogenicity exclusively induce expression of inflammatory genes in target tissues. Moreover, gene expression profile and histopathological findings in the kidney are similar to those observed in the liver of GVHD mice. Bone Marrow Transplantation (2013) 48, 284–293; doi:10.1038/bmt.2012.120; published online 23 July 2012 Keywords: gene expression; GVHD; kidney; target tissues; mouse model INTRODUCTION none of these reports describe any changes in gene expression Allo-SCT is the treatment of choice for a variety of malignant and profile of non-target tissues like muscle.
    [Show full text]
  • Allergic Reactions After Vaccination: Translating Guidelines Into Clinical Practice
    R E V I E W EUR ANN ALLERGY CLIN IMMUNOL VOL 51, N 2, 51-61, 2019 A. RADICE1, G. CARLI2, D. MACCHIA1, A. FARSI2 Allergic reactions after vaccination: translating guidelines into clinical practice 1SOS Allergologia e Immunologia, Firenze, Azienda USL Toscana Centro, Italy 2SOS Allergologia e Immunologia, Prato, Azienda USL Toscana Centro, Italy KEYWORDS Summary vaccine; vaccination; allergic reactions; Vaccination represents one of the most powerful medical interventions on global health. anaphylaxis; vaccine hesitancy; vaccine Despite being safe, sustainable, and effective against infectious and in some cases also components; desensitization non-infectious diseases, it’s nowadays facing general opinion’s hesitancy because of a false perceived risk of adverse events. Adverse reactions to vaccines are relatively rare, instead, and those recognizing a hypersensitivity mechanism are even rarer. Corresponding author The purpose of this review is to offer a practical approach to adverse events after vaccina- Anna Radice Ospedale San Giovanni di Dio tion, focusing on immune-mediated reactions with particular regard to their recognition, Via Torregalli 3, 50143 Firenze diagnosis and management. Phone: +39 055 6932304 According to clinical features, we propose an algorythm for allergologic work-up, which E-mail: [email protected] helps in confirming hypersensitivity to vaccine, nonetheless ensuring access to vaccination. Finally, a screening questionnaire is included, providing criteria for immunisation in spe- Doi cialized care settings. 10.23822/EurAnnACI.1764-1489.86 Introduction The gain from vaccination is not just about human health, but it is also a matter of financial resources for health systems. “Smallpox is dead” stated the magazine of the World Health It has been calculated that for every dollar spent in vaccines, Organisation (WHO) in 1980.
    [Show full text]
  • Difference Between Hypersensitivity and Autoimmunity Key Difference – Hypersensitivity Vs Autoimmunity
    Difference Between Hypersensitivity and Autoimmunity www.differencebetwee.com Key Difference – Hypersensitivity vs Autoimmunity Autoimmunity is an adaptive immune response mounted against self-antigens. In simple terms, when your body is acting against its own cells and tissues, this is called an autoimmune reaction. An exaggerated and inappropriate immune response to an antigenic stimulus is defined as a hypersensitivity reaction. Unlike autoimmune reactions that are triggered only by the endogenous antigens, hypersensitivity reactions are triggered by both endogenous and exogenous antigens. This is the key difference between hypersensitivity and autoimmunity. What is Hypersensitivity? An exaggerated and inappropriate immune response to an antigenic stimulus is defined as a hypersensitivity reaction. The first exposure to a particular antigen activates the immune system and, antibodies are produced as a result. This is called sensitization. Subsequent exposures to the same antigen give rise to hypersensitivity. Few important facts regarding the hypersensitivity reactions are given below They can be elicited by both exogenous and endogenous agents. They are a result of an imbalance between the effector mechanisms and the countermeasures that are there to control any inappropriate execution of an immune response. The presence of a genetic susceptibility increases the likelihood of hypersensitivity reactions. The manner in which hypersensitivity reactions harm our body is similar to the way that the pathogens are destroyed by immune reactions. Figure 01: Allergy According to the Coombs and Gell classification, there are four main types of hypersensitivity reactions. Type I- Immediate Type/ Anaphylactic Mechanism Vasodilation, edema, and contraction of smooth muscles are the pathological changes that take place during the immediate phase of the reaction.
    [Show full text]
  • Ii Vasclitides
    ا يمون وپات وژنز واسکوليتھااکلتا Vascliiitides: The Immunopa tho genes is دکتر محمدمھدی محمدی LMD, PhD, MPH ([email protected]) The 7th International 12th National Congress on Quality Improvement in Clinical Laboratories 28 Farvardin 1393 / 17April 2014 , Tehran, Iran A small spoonful of Terminology (in Farsi بيماريزايی) – .path·o·gen·e·sis, n • – the ppp(roduction and development of disease (events and reactions and other pathologic mechanisms) . Also, pa·thog·e·ny !?! (in Farsi بيماريزايی) _ .path·o·ge·nic·i·ty, n • – the disease-producing capacity of a pathogen. [PATHOGENIC + -ITY] • vir·u·lence, n. – the relative ability of a microorganism to cause disease; degree of pathogenicity. • Vasculitis, n. (vasculitides, plural) – a general term for vessel wall inflammation, systemic or localized, immune-mediated or directly invaded by microbes. • Infections may indirectly generate vasculitis, e.g. through IC formation or by X_reaction. Note that immunosuppressive therapy is only appropriate for --?– type! • WHAT R the IMMUNE MECHANISMS in VASCULITIS? افراط تعادل تفريط Immunodeficiency Allergy (& Infection) Defence Immunodeficiency Surveillance Autoimmunity (& Malignancy) Homostasis ?! Some Inter-related Concepts Immunological Vasculitis Hypersensitivity Auoimmunity Tolerance EDUCATION? Tolerance in different classic Txtbks of Immunology (Abbas, Benjamini, Janeway, Kuby, Roitt, Stites …) • Tolerance (by C&M Immunology): – Unresponsiveness of the adaptive immune system to antigens, as a result of inactivation or death of antigen-specific lymphocytes, induced by exposure to the antigens. – (()Active) Unresponsiveness of the (()HEALTHY) adappytive immune system to (selected) antigens, as a result of (i.e. MECHANISMS:) inactivation or death of antigen-specific lymphocytes, induced by exposure to those antigens. • Tolerance to self antigens is a normal feature of the adaptive immune system, but tolerance to foreign antigens may be induced undtiditiftider certain conditions of antigen exposure.
    [Show full text]
  • An Avoidable Cause of Thymoglobulin Anaphylaxis S
    Brabant et al. Allergy Asthma Clin Immunol (2017) 13:13 Allergy, Asthma & Clinical Immunology DOI 10.1186/s13223-017-0186-9 CASE REPORT Open Access An avoidable cause of thymoglobulin anaphylaxis S. Brabant1*, A. Facon2, F. Provôt3, M. Labalette1, B. Wallaert4 and C. Chenivesse4 Abstract Background: Thymoglobulin® (anti-thymocyte globulin [rabbit]) is a purified pasteurised, gamma immune globulin obtained by immunisation of rabbits with human thymocytes. Anaphylactic allergic reactions to a first injection of thymoglobulin are rare. Case presentation: We report a case of serious anaphylactic reaction occurring after a first intraoperative injection of thymoglobulin during renal transplantation in a patient with undiagnosed respiratory allergy to rabbit allergens. Conclusions: This case report reinforces the importance of identifying rabbit allergy by a simple combination of clini- cal interview followed by confirmatory skin testing or blood tests of all patients prior to injection of thymoglobulin, which is formally contraindicated in patients with a history of hypersensitivity to rabbit proteins. Keywords: Thymoglobulin, Anaphylactic allergic reaction, Rabbit proteins Background [7]. Cases of serious anaphylactic reactions to thymo- Thymoglobulin is an IgG fraction purified from the globulin due to rabbit protein allergy are very rare, and serum of rabbits immunised against human thymocytes. consequently, specific tests for rabbit allergy are not The preparation consists of polyclonal antilymphocyte usually performed as part of the pre-transplant assess- IgG directed against T lymphocyte surface antigens, and ment. We report a case of serious anaphylactic reaction induction of profound lymphocyte depletion is though due to rabbit protein allergy following a first injection of to be the main mechanism of thymoglobulin-mediated thymoglobulin.
    [Show full text]
  • Food Fact Sheet: Food Allergy and Food Intolerance
    Food Fact Sheet: Food Allergy and Food Intolerance Having to avoid certain foods in your diet can be difficult. But there are a few simple things you can do to help you manage your food allergies - allowing you to stay safe, continue to participate in fun activities and enjoy your food. What is the difference between food allergy and food intolerance? For some people, eating certain foods can lead to an unpleasant and sometimes dangerous physical reaction. The term used to describe all types of reactions to foods is ‘food hypersensitivity’. A 'food allergy' is a reaction involving the immune system (the body’s defence against foreign bodies). Those that do not involve the immune system are often called a ‘food intolerance’. It is important to identify and manage foods that trigger any symptoms in an appropriate way. Food allergy Proteins within foods can trigger immediate (within two hours) or delayed symptoms (up to several days later). Immediate food allergy (IgE mediated food allergy) Immediate reactions to foods occur when your immune system reacts to a normally harmless protein in food, due to the creation of Immunoglobulin E (IgE). This results in the release of chemicals (e.g. histamine) which trigger allergic symptoms. These symptoms are usually in the skin (itching/swelling), or gut (vomiting, diarrhoea). Other symptoms can include breathing problems and in rare cases an extreme allergic reaction called anaphylaxis. Delayed food allergy (non IgE mediated food allergy) Delayed reactions to foods still involve your immune system, but there is a different type of immune reaction involved. Symptoms typically occur in the gut (vomiting, diarrhoea, constipation) and/or the skin (atopic eczema).
    [Show full text]
  • Allergy, Hypersensitivity, Angioedema, and Anaphylaxis Episode Overview
    CrackCast Show Notes –Allergy and Anaphylaxis – October 2017 www.canadiem.org/crackcast Chapter 109 – Allergy, Hypersensitivity, Angioedema, and Anaphylaxis Episode Overview Key Points: 1. A history of sudden urticarial rash accompanied by respiratory difficulty, abdominal pain, or hypotension, strongly favors the diagnosis of anaphylaxis. 2. Epinephrine is the first-line treatment in patients with anaphylaxis: give it immediately. 3. There are no absolute contraindications to the use of epinephrine in the setting of anaphylaxis. 4. Antihistamines and corticosteroids are second- and third-line agents in the management of anaphylaxis and should not replace or precede epinephrine. 5. Consider prolonged observation or admission for patients who: a. Experience protracted anaphylaxis, hypotension, or airway involvement; b. Receive IV epinephrine or more than two doses of IM epinephrine; c. Or have poor outpatient social support. 6. Patients discharged after an anaphylactic event should be prescribed an EpiPen and instructed on its use. 7. Patients with refractory hypotension may require glucagon (receiving beta-blockage) or a continuous IV epinephrine infusion. 8. Non-histaminergic angioedema (non-allergic angioedema) does not typically respond to epinephrine and antihistamines. New drugs, including berinert, icatibant, ecallantide, and Ruconest have been approved for use in HAE. FFP has been used with varying success in HAE, ACID, and ACE inhibitor–induced angioedema. NOTE: ACID: acquired C1 esterase deficiency (ACED) Core Questions: 1. List the four types of Gell and Coombs classifications of immune reaction and give examples of each 2. List four etiologic agents causing anaphylaxis by immunologic mechanisms 3. List six mediators of anaphylaxis and their physiologic actions and clinical manifestations 4.
    [Show full text]
  • Hypersensitivity Reactions (Types I, II, III, IV)
    Hypersensitivity Reactions (Types I, II, III, IV) April 15, 2009 Inflammatory response - local, eliminates antigen without extensively damaging the host’s tissue. Hypersensitivity - immune & inflammatory responses that are harmful to the host (von Pirquet, 1906) - Type I Produce effector molecules Capable of ingesting foreign Particles Association with parasite infection Modified from Abbas, Lichtman & Pillai, Table 19-1 Type I hypersensitivity response IgE VH V L Cε1 CL Binds to mast cell Normal serum level = 0.0003 mg/ml Binds Fc region of IgE Link Intracellular signal trans. Initiation of degranulation Larche et al. Nat. Rev. Immunol 6:761-771, 2006 Abbas, Lichtman & Pillai,19-8 Factors in the development of allergic diseases • Geographical distribution • Environmental factors - climate, air pollution, socioeconomic status • Genetic risk factors • “Hygiene hypothesis” – Older siblings, day care – Exposure to certain foods, farm animals – Exposure to antibiotics during infancy • Cytokine milieu Adapted from Bach, JF. N Engl J Med 347:911, 2002. Upham & Holt. Curr Opin Allergy Clin Immunol 5:167, 2005 Also: Papadopoulos and Kalobatsou. Curr Op Allergy Clin Immunol 7:91-95, 2007 IgE-mediated diseases in humans • Systemic (anaphylactic shock) •Asthma – Classification by immunopathological phenotype can be used to determine management strategies • Hay fever (allergic rhinitis) • Allergic conjunctivitis • Skin reactions • Food allergies Diseases in Humans (I) • Systemic anaphylaxis - potentially fatal - due to food ingestion (eggs, shellfish,
    [Show full text]
  • Arthus Reaction
    The Journal of Emergency Medicine, Vol. 56, No. 4, pp. 450–451, 2019 Ó 2018 Elsevier Inc. All rights reserved. 0736-4679/$ - see front matter https://doi.org/10.1016/j.jemermed.2018.12.047 Visual Diagnosis in Emergency Medicine ARTHUS REACTION Mei-Hua Wang, RN,* Alvin Hu,† Yei-Soon Lee, MD,* and Chih-Cheng Lai, MD‡ *Department of Emergency Department, Chi Mei Medical Center, Liouying, Taiwan, †Poznan University of Medical Sciences, Poznan, Poland, and ‡Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Taiwan Reprint Address: Chih-Cheng Lai, MD, Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan CASE REPORT 0–4%), respectively, and a C-reactive protein level of 9.1 mg/L. Blood culture was collected but showed no bac- A 6-year-old boy presented to the emergency department terial growth. Physical examination showed an erythem- (ED) with fever and skin rash (Figure 1) over his left atous skin rash with swelling and severe pain over the thigh. He had just received a combination vaccine with vaccination site. Acetaminophen was given for pain relief diphtheria, tetanus, pertussis, and poliomyelitis (DTaP- and fever. Steroid (methylprednisolone 20 mg every 8 h) IPV) on his left thigh 12 h prior to his visit to the ED. and an antihistamine (cyproheptadine 2 mg three times a His vital signs were body temperature of 36.6C, respira- day) were prescribed for suspected allergic reaction. Af- tory rate of 20 breaths/min, blood pressure of 104/83 mm ter treatment, the fever subsided and the painful swelling Hg, and heart rate of 100 beats/min.
    [Show full text]
  • Immune Pathology Immune System Functions Reactivity to Tolerance Nonshared Ag to Self-Ag
    Immune Pathology Immune system functions reactivity to tolerance nonshared Ag to self-Ag reduction pErVeRsIoN malfunction immunodeficiency hypersensitivity autoimmune diseases Hypersensitivity Hypersensitivity - excessive or inadequate manifestation adaptive immune of reactions Can manifest as local and systemic reactions Hypersensitivity Type Synonym Immunological mechanisms I IgE-mediated, anaphylactic, IgE-mediated degranulation of mast reaginic, HIS (blood cells dyscrasia) II antibody-dependent Cytotoxic antibodies activate cytotoxicity complement, which leads to cell lysis III immune complex Immune complexes activate leukocytes IV cell-mediated, delayed-type Cytokine production by hypersensitivity macrophages and lymphocytes V antibody-dependent Antibodies alter functional state of functional changes cells by interacting with its receptor Type I hypersensitivity • Speed ​​of reaction - seconds or minutes • IgE-mediated • Chemical mediators of damage - vasoactive products of mast cells / basophils (histamine, arachidonic acid derivatives) • Mechanism - accumulation of of neutrophils, unstriated muscle spasm Type I hypersensitivity • bronchial asthma (some forms) • anaphylactic shock • Urticaria • Quincke's edema • dietary allergy • nasal allergy • allergic conjunctivitis Mast cell Аг Synthesis and secretion: leukotrienes (LTC4, LTB4), prostaglandins (PGD2), degranulation: IL-3, 4,5,6 histamine Platelet-activating factor serotonin (PAF) eotoxin Type I hypersensitivity Morphological manifestations IHS: • exudative alterative inflammation
    [Show full text]
  • Anaphylaxis Following Administration of Extracorporeal Photopheresis for Cutaneous T Cell Lymphoma
    Volume 26 Number 9| September 2020| Dermatology Online Journal || Letter 26(9):18 Anaphylaxis following administration of extracorporeal photopheresis for cutaneous T cell lymphoma Jessica Tran1,2, Lisa Morris3, Alan Vu4, Sampreet Reddy1, Madeleine Duvic1 Affiliations: 1Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA, 2Baylor College of Medicine, Houston, Texas, USA, 3University of Missouri Columbia School of Medicine, Columbia, Missouri , USA, 4University of Texas McGovern Medical School, Houston, Texas, USA Corresponding Author: Madeleine Duvic MD, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Unit 1452, 1515 Holcombe Boulevard, Houston, TX 77030, Tel: 713-792-6800, Email: [email protected] peripheral blood from a patient, (ii) separating the Abstract white blood cells from whole blood by Extracorporeal photopheresis is a non-invasive centrifugation, (iii) adding psoralen, a therapy used for the treatment of a range of T cell photosensitizing agent, to the white blood cells, (iv) disorders, including cutaneous T cell lymphoma. exposing the white blood cells to ultraviolet A (UVA) During extracorporeal photopheresis, peripheral radiation, and (v) re-infusing the treated white blood blood is removed from the patient and the white blood cells are separated from whole blood via cells to the patient [3]. The re-infusion of apoptotic centrifugation. The white blood cells are exposed to leukocytes triggers an immune response resulting in psoralen (a photosensitizing agent) and ultraviolet A production of CD8+ tumor suppressor cells in CTCL radiation, causing cell apoptosis. The apoptotic [3]. Extracorporeal photopheresis is generally leukocytes are subsequently re-infused into the regarded as safe with few side effects [3].
    [Show full text]